HIGH · 8.8

CVE-2023-6078

An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary c...

Vulnerability Description

An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary command execution.

CVSS Score

8.8

HIGH

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality
HIGH
Integrity
HIGH
Availability
HIGH

Affected Products

VendorProductVersions
3DsBiovia Materials Studio>= 2021, <= 2023

Related Weaknesses (CWE)

References

FAQ

What is CVE-2023-6078?

CVE-2023-6078 is a vulnerability with a CVSS score of 8.8 (HIGH). An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary c...

How severe is CVE-2023-6078?

CVE-2023-6078 has been rated HIGH with a CVSS base score of 8.8/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-6078?

Check the references section above for vendor advisories and patch information. Affected products include: 3Ds Biovia Materials Studio.